
Chiral Organic Compounds
Chiral organic compounds are molecules that possess non-superimposable mirror images, a property known as chirality, which plays a crucial role in various chemical and biological processes. These compounds are essential in the development of pharmaceuticals, agrochemicals, and fine chemicals, where the specific orientation of molecules can significantly impact their function and efficacy. At CymitQuimica, we offer a comprehensive range of high-purity chiral organic compounds, including enantiomers and diastereomers, meticulously sourced and tested to meet the stringent demands of both research and industrial applications. Our catalog includes chiral catalysts, auxiliaries, and building blocks that are pivotal in asymmetric synthesis and stereoselective reactions. By providing top-quality chiral organic compounds, we support researchers and professionals in achieving precise and efficient stereochemical outcomes, driving advancements and innovation in fields such as medicinal chemistry, biotechnology, and materials science.
Products of "Chiral Organic Compounds"
Sort by
1,2-Pyrrolidinedicarboxylic acid, 5-oxo-, bis(1,1-dimethylethyl) ester,(2S)-
CAS:Formula:C14H23NO5Purity:97%Color and Shape:SolidMolecular weight:285.3361(R)-2-((1-Phenylethyl)carbamoyl)benzoic acid
CAS:Formula:C16H15NO3Purity:97%Color and Shape:SolidMolecular weight:269.2952Tylosin 3-Acetate
CAS:Controlled ProductApplications A new acyl derivative of Tylosin (T947650) produced by microbial transformation. References Okamoto, R., et al.: J. Antibiotics, 33, 1300 (1980),Formula:C48H79NO18Color and Shape:WhiteMolecular weight:958.143-Morpholinecarboxylic acid, 5-oxo-4-(phenylmethyl)-, (±)-
CAS:Formula:C12H13NO4Purity:97%Color and Shape:SolidMolecular weight:235.2359β-D-Glucopyranoside, 4-methoxyphenyl 2-deoxy-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-3,6-bis-O-(phenylmethyl)-, 4-acetate
CAS:Formula:C37H35NO9Purity:98%Color and Shape:SolidMolecular weight:637.6751Diisopropyl L-(+)-Tartrate
CAS:Formula:C10H18O6Purity:>98.0%(GC)Color and Shape:Colorless to Almost colorless clear liquidMolecular weight:234.25N-Benzyl-N-((1S,2R)-1-hydroxy-1-phenylpropan-2-yl)-2,4,6-trimethylbenzenesulfonamide
CAS:Formula:C25H29NO3SPurity:98%Molecular weight:423.5677Benzeneethanol, β-amino-4-fluoro-, hydrochloride (1:1), (βS)-
CAS:Formula:C8H11ClFNOPurity:95%Color and Shape:SolidMolecular weight:191.6304(2E)-2-[(3,5-Dibromo-2-hydroxyphenyl)methylene]hydrazide-3-pyridinecarboxylic Acid
CAS:Formula:C13H9Br2N3O2Purity:97%Color and Shape:SolidMolecular weight:399.0375(9S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-{(2R)-1-[(3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone
CAS:Formula:C51H79NO13Purity:98%Color and Shape:SolidMolecular weight:914.1719Ref: IN-DA0035KC
1g111.00€5g284.00€10g518.00€25gTo inquire10mg30.00€100mg39.00€250mg50.00€500mg75.00€(S)-4-Benzylthiazolidine-2-thione
CAS:Formula:C10H11NS2Purity:97%Color and Shape:SolidMolecular weight:209.33104(S)-Methyl 2,2-dimethyl-1,3-dioxolane-4-carboxylate
CAS:Formula:C7H12O4Purity:97%Color and Shape:LiquidMolecular weight:160.1678L-Alanine, 3-[[(1,1-dimethylethoxy)carbonyl]amino]-, methyl ester, hydrochloride (1:1)
CAS:Formula:C9H19ClN2O4Purity:97%Color and Shape:SolidMolecular weight:254.7112(S)-2,5-Diaminopentanoic acid compound with (S)-2-aminosuccinic acid (1:1)
CAS:Formula:C9H19N3O6Purity:95%Color and Shape:SolidMolecular weight:265.26366N-Acetyl-L-valinamide
CAS:Formula:C7H14N2O2Purity:97%Color and Shape:SolidMolecular weight:158.19825999999998(2R,3S)-5-Chloro-2-(((4-chlorobenzoyl)oxy)methyl)tetrahydrofuran-3-yl 4-chlorobenzoate
CAS:Formula:C19H15Cl3O5Purity:90%Color and Shape:SolidMolecular weight:429.6784(R,R)-2,2'-Isopropylidenebis(4-isopropyl-2-oxazoline)
CAS:Formula:C15H26N2O2Purity:>98.0%(GC)Color and Shape:Colorless to Light yellow clear liquidMolecular weight:266.39Potassium (R)-oxirane-2-carboxylate
CAS:Formula:C3H4KO3Purity:97%Color and Shape:SolidMolecular weight:127.16036Benzenepropanoic acid,b-[[(1,1-dimethylethoxy)carbonyl]amino]-4-fluoro-, (bS)-
CAS:Formula:C14H18FNO4Purity:98%Color and Shape:SolidMolecular weight:283.29543(S)-3-Hydroxymethyl-3,4-dihydro-1H-isoquinoline-2-carboxylic acid tert-butyl ester
CAS:Formula:C15H21NO3Purity:97%Molecular weight:263.3321Z-L-phenylalanine methyl ester
CAS:Formula:C18H19NO4Purity:98%Color and Shape:LiquidMolecular weight:313.34788H-Indeno[1,2-d]oxazole, 2,2'-methylenebis[3a,8a-dihydro-, (3aS,3'aS,8aR,8'aR)-
CAS:Formula:C21H18N2O2Purity:98%Color and Shape:SolidMolecular weight:330.3798(3R)-3-amino-1-(tert-butoxycarbonyl)-pyrrolidine
CAS:Formula:C9H18N2O2Purity:97%Color and Shape:LiquidMolecular weight:186.2514Leucomycin V, 3-acetate 4B-(3-methylbutanoate)
CAS:Formula:C42H69NO15Purity:95%Color and Shape:SolidMolecular weight:827.995Cholest-5-en-3-ol (3β)-, 3-(hydrogen butanedioate)
CAS:Formula:C31H50O4Purity:95%Color and Shape:SolidMolecular weight:486.7263TRANS,TRANS-4-(4-FLUOROPHENYL)-4''-PROPYL-BICYCLOHEXYL
CAS:Formula:C21H31FPurity:97%Color and Shape:SolidMolecular weight:302.46924321-Piperidinecarboxylic acid, 3-amino-4-hydroxy-, phenylmethyl ester, (3R,4R)-
CAS:Formula:C13H18N2O3Purity:98%Molecular weight:250.2936(S,S)-N-(p-Toluenesulfonyl)-1,2-diphenylethanediamine(chloro)(p-cymene)ruthenium(II)
CAS:Formula:C31H35ClN2O2RuSPurity:97%Color and Shape:SolidMolecular weight:636.2098000000003Ethyl (11bR)-4-Amino-2,6-bis(3,5-di-tert-butylphenyl)-4,5-dihydro-3H-cyclohepta[1,2-a:7,6-a']dinaphthalene-4-carboxylate
CAS:Formula:C54H63NO2Purity:>97.0%(HPLC)Color and Shape:White to Almost white powder to crystalMolecular weight:758.10L-Phenylalanine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-2-nitro-
CAS:Formula:C24H20N2O6Purity:95%Color and Shape:SolidMolecular weight:432.42541-Piperazinecarboxylic acid, 2,5-dimethyl-, 1,1-dimethylethyl ester, (2R,5R)-
CAS:Formula:C11H22N2O2Purity:95%Color and Shape:LiquidMolecular weight:214.30458000000004(3R,4S)-3-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-4-methylhexanoic acid
CAS:Formula:C22H25NO4Purity:98%Color and Shape:SolidMolecular weight:367.43821H-Pyrazole, 1-phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
CAS:Formula:C15H19BN2O2Purity:97%Color and Shape:SolidMolecular weight:270.13461H-Isoindole-1,3(2H)-dione, 2-[(2R)-2-oxiranylmethyl]-
CAS:Formula:C11H9NO3Purity:98%Color and Shape:SolidMolecular weight:203.1941(2R,4S)-1-(tert-butoxycarbonyl)-4-fluoropyrrolidine-2-carboxylic acid
CAS:Formula:C10H16FNO4Purity:95%Color and Shape:SolidMolecular weight:233.2367Ref: IN-DA00FFBT
1g89.00€5g193.00€10g326.00€25g613.00€50gTo inquire100gTo inquire100mg30.00€250mg50.00€Fluvastatin sodium
CAS:Formula:C24H26FNNaO4Purity:98%Color and Shape:SolidMolecular weight:434.4557132(1R,4S)-1-Methyl-4-(prop-1-en-2-yl)cyclohex-2-enol
CAS:Formula:C10H16OPurity:95%Color and Shape:LiquidMolecular weight:152.2334Butanamide, 2-amino-4-(methylthio)-, hydrochloride (1:1), (2S)-
CAS:Formula:C5H13ClN2OSPurity:98%Color and Shape:SolidMolecular weight:184.6875Vincristine-d3 Sulfate
CAS:Controlled ProductApplications Labelled Vincristine. An antitumor alkaloid isolated from Vinca rosea Linn. An antineoplastic. Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Burns, J.H., et al.: Anal. Profiles Drug Subs., 1, 463 (1972), Owellen, D., et al.: J. Med. Chem., 15, 894 (1972),Formula:C46H53D3N4O10·H2SO4Color and Shape:NeatMolecular weight:926.05L-Alanine, N-[(1,1-dimethylethoxy)carbonyl]-, 2-oxo-2-phenylethyl ester
CAS:Formula:C16H21NO5Purity:98%Color and Shape:SolidMolecular weight:307.34163-Pyrrolidinamine, 1-(phenylmethyl)-, hydrochloride (1:2), (3S)-
CAS:Formula:C11H18Cl2N2Purity:97%Color and Shape:SolidMolecular weight:249.18002000000004(3R)-3-amino-3-(2,4-difluorophenyl)propanoic acid hydrochloride
CAS:Formula:C9H10ClF2NO2Purity:95%Color and Shape:SolidMolecular weight:237.6313-Isoquinolinecarboxylic acid, 1,2,3,4-tetrahydro-, (3S)-
CAS:Formula:C10H11NO2Purity:98%Color and Shape:SolidMolecular weight:177.199839999999975'-Inosinic acid, 2'-deoxy-, sodium salt (1:2)
CAS:Formula:C10H11N4Na2O7PPurity:98%Color and Shape:SolidMolecular weight:376.1702L-Phenylalanine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-3,4,5-trifluoro-
CAS:Formula:C24H18F3NO4Purity:96%Color and Shape:SolidMolecular weight:441.3992trans-2-[4-[(N-tert-Butoxycarbonyl)amino]cyclohexyl]ethyl methanesulfonate
CAS:Formula:C14H27NO5SPurity:95%Molecular weight:321.43294-Pyridinepropanoic acid, α-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-, (αR)-
CAS:Formula:C23H20N2O4Purity:95%Color and Shape:SolidMolecular weight:388.41593-Pyrrolidinecarboxylic acid, 3-methyl-, (3R)-
CAS:Formula:C6H11NO2Purity:97%Color and Shape:SolidMolecular weight:129.15704(S)-2-[[2-[Hydroxybis(4-methoxyphenyl)methyl]pyrrolidin-1-yl]methyl]-6-[hydroxydi(naphthalen-1-yl)methyl]-4-methylphenol
CAS:Formula:C48H45NO5Purity:>90.0%(HPLC)(qNMR)Color and Shape:White to Light yellow to Light orange powder to crystalMolecular weight:715.89Ximelagatran
CAS:Controlled ProductStability Hygroscopic Applications An orally active direct thrombin inhibitor; prodrug of Melagatran. Antithrombotic. References Owens, P.K., et al.: J. Pharm. Biomed. Anal., 27, 587 (2002), Kalus, J.S., et al.: Expert Opin. Invest. Drugs, 13, 465 (2004), Boos, C.J., et al.: Eur. J. Int. Med., 16, 267 (2005), Cullberg, M., et al.: Clin. Pharmacol. Ther., 77, 279 (2005),Formula:C24H35N5O5Color and Shape:NeatMolecular weight:473.57(R)-3-Aminopyrrolidin-2-one hydrochloride
CAS:Formula:C4H9ClN2OPurity:95%Color and Shape:SolidMolecular weight:136.58015-[(3S)-Dithiolan-3-yl]pentanoic acid
CAS:Formula:C8H14O2S2Purity:97%Color and Shape:SolidMolecular weight:206.32556000000002D-Phenylalanine ethyl ester hydrochloride
CAS:Formula:C11H16ClNO2Purity:97%Color and Shape:SolidMolecular weight:229.7032Carbamic acid, N-[(1R,2S)-2-(aminomethyl)cyclohexyl]-, 1,1-dimethylethyl ester, rel-
CAS:Formula:C12H24N2O2Purity:98%Color and Shape:SolidMolecular weight:228.3312(3aS,6aS)-1-Methyl-hexahydropyrrolo[3,4-b]pyrrole Dihydrochloride
CAS:Formula:C7H15ClN2Purity:97%Molecular weight:162.6604Isopimaric Acid
CAS:Controlled ProductApplications A potent novel activators of large-conductance Ca2+-activated K+ channel. Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Imaizumei, Y. et al.: Mol. Pharmacol., 62, 836 (2002); Chang, S. et al.: AM. J. Physiol., 298, F1416 (2010);Formula:C20H30O2Purity:>90%Color and Shape:Off-WhiteMolecular weight:302.45(1S,4S)-1,7,7-Trimethylbicyclo[2.2.1]heptan-2-one
CAS:Formula:C10H16OPurity:98%Color and Shape:SolidMolecular weight:152.2334A 54556A (~90%)
CAS:Controlled ProductFormula:C38H50N6O8Purity:~90%Color and Shape:NeatMolecular weight:718.84Salinomycin sodium salt
CAS:Formula:C42H69NaO11Purity:98%Color and Shape:SolidMolecular weight:772.9804(2S,4R)-tert-Butyl 4-((tert-butyldimethylsilyl)oxy)-2-(hydroxymethyl)pyrrolidine-1-carboxylate
CAS:Formula:C16H33NO4SiPurity:95%Color and Shape:SolidMolecular weight:331.523(S)-(-)-XylBINAP
CAS:Formula:C52H48P2Purity:>97.0%(HPLC)Color and Shape:White to Almost white powder to crystalMolecular weight:734.90(3R,5S)-Atorvastatin Sodium Salt
CAS:Controlled ProductStability Hygroscopic Applications Atorvastatin impurity in bulk drug and tablets. References Posvar, E., et al.: J. Clin. Pharmacol., 36, 728 (1996), Lea, A., et al.: Drugs, 53, 828 (1997), Miao, X., et al.: J. Chromatogr., 998, 133 (2003),Formula:C33H34FN2O5·NaColor and Shape:NeatMolecular weight:580.623-Piperidinecarboxylic acid, 4-[[(1,1-dimethylethoxy)carbonyl]amino]-, methyl ester, (3R,4R)-rel-
CAS:Formula:C12H22N2O4Purity:97%Color and Shape:SolidMolecular weight:258.31413-Furanmethanol, tetrahydro-, (3S)-
CAS:Formula:C5H10O2Purity:97%Color and Shape:LiquidMolecular weight:102.1317(4S)-4-(propan-2-yl)-1,3-oxazolidin-2-one
CAS:Formula:C6H11NO2Purity:97%Color and Shape:SolidMolecular weight:129.157Dimethyl L-(+)-Tartrate
CAS:Formula:C6H10O6Purity:>98.0%(GC)Color and Shape:White to Almost white powder to crystalMolecular weight:178.14(R)-2-(4-Hydroxyphenoxy)propanoic acid
CAS:Formula:C9H10O4Purity:98%Color and Shape:SolidMolecular weight:182.1733Glycine, N,N'-(1R,2R)-1,2-cyclohexanediylbis[N-(carboxymethyl)-, hydrate (1:1), rel-
CAS:Formula:C14H24N2O9Purity:98%Color and Shape:SolidMolecular weight:364.34835999999984Alpha-Zearalenol-d7
CAS:Controlled ProductFormula:C18H17D7O5Color and Shape:Off White SolidMolecular weight:327.42(1S,2S,6R,8S)-2,9,9-trimethyl-4-(2-methylpropyl)-3,5-dioxa-4-boratricyclo[6.1.1.0^{2,6}]decane
CAS:Formula:C14H25BO2Purity:95%Color and Shape:LiquidMolecular weight:236.1581(S)-2-Amino-4-(methylsulfonyl)butanoic acid
CAS:Formula:C5H11NO4SPurity:98%Color and Shape:SolidMolecular weight:181.2101(R)-1-(Naphthalen-1-yl)ethanamine
CAS:Formula:C12H13NPurity:95%Color and Shape:LiquidMolecular weight:171.23832000000002L-tert-Leucine Methylamide
CAS:Formula:C7H16N2OPurity:98%Color and Shape:SolidMolecular weight:144.21471,2-Cyclopropanedicarboxylic acid, monomethyl ester, (1R,2S)-rel-
CAS:Formula:C6H8O4Purity:98%Color and Shape:SolidMolecular weight:144.12532D-Glutamic acid, 1,5-bis(phenylmethyl) ester, 4-methylbenzenesulfonate (1:1)
CAS:Formula:C26H29NO7SPurity:97%Color and Shape:SolidMolecular weight:499.576Butanoic acid, 4-amino-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-, (2S)-
CAS:Formula:C19H20N2O4Purity:98%Color and Shape:SolidMolecular weight:340.3731(S)-(-)-4-(METHOXYMETHYL)-1,3-DIOXOLAN-2-ONE
CAS:Formula:C5H8O4Purity:98%Color and Shape:LiquidMolecular weight:132.1146(R)-(-)-4-Benzyl-3-propionyl-2-oxazolidinone
CAS:Formula:C13H15NO3Purity:97%Color and Shape:SolidMolecular weight:233.2631(s)-(-)-1-phenylethylamine
CAS:Formula:C8H11NPurity:98%Color and Shape:Colorless LiquidMolecular weight:121.1796Pyridine, 2-[(S)-(4-chlorophenyl)(4-piperidinyloxy)methyl]-
CAS:Formula:C17H19ClN2OPurity:96%Color and Shape:LiquidMolecular weight:302.79862-[[(1S)-1-(3-Butyn-1-yl)hexyl]oxy]tetrahydro-2H-pyran
CAS:Formula:C15H26O2Purity:95%Color and Shape:SolidMolecular weight:238.3657(S)-1-Phenylpropan-1-amine
CAS:Formula:C9H13NPurity:95%Color and Shape:LiquidMolecular weight:135.206221H-Imidazole, 5-[(1S)-1-(2,3-dimethylphenyl)ethyl]-, hydrochloride (1:1)
CAS:Formula:C13H17ClN2Purity:98%Color and Shape:SolidMolecular weight:236.7405L-Valine, N-[(1,1-dimethylethoxy)carbonyl]-N-methyl-
CAS:Formula:C11H21NO4Purity:97%Color and Shape:SolidMolecular weight:231.2887L-Valine, N-acetyl-, methyl ester
CAS:Formula:C8H15NO3Purity:95%Color and Shape:SolidMolecular weight:173.2096(S)-N-[2-(1,6,7,8-Tetrahydro-2H-indeno-[5,4-b]furan-8-yl)ethyl]propionamide
CAS:Formula:C16H21NO2Purity:98%Color and Shape:SolidMolecular weight:259.3434(R)-2-Amino-3-methoxypropanoic acid
CAS:Formula:C4H9NO3Purity:97%Color and Shape:SolidMolecular weight:119.1192(R)-2-AMINOMETHYL-1-N-CBZ-PYRROLIDINE
CAS:Formula:C13H18N2O2Purity:95%Color and Shape:LiquidMolecular weight:234.2942200000000211beta,17alpha-Dihydroxy-17-[(phosphonooxy)methyl]-D-homoandrosta-1,4-diene-3,17a-dione (>85%)
Controlled ProductImpurity Prednisolone Sodium Phosphate USP Impurity A Stability Hygroscopic Applications 11β,17α-Dihydroxy-17-[(phosphonooxy)methyl]-D-homoandrosta-1,4-diene-3,17a-dione is a derivative of Prednisolone (P703740); a glucocorticosteroid that is used to treat patients with chronic obstructive pulmonary disease (COPD). References Burge, P., et al.: Thorax, 58, 654 (2003); Mendenhall, C., et al.: New Engl. J. Med., 311, 1464 (1984)Formula:C21H29O8PPurity:>85%Color and Shape:NeatMolecular weight:440.42(R)-2,2',3,3'-Tetrahydro-1,1'-spirobi[1H-indene]-7,7'-diol
CAS:Formula:C34H32O4Purity:98%Color and Shape:SolidMolecular weight:504.6155Ref: IN-DA0072SK
1gTo inquire5mg70.00€10mg129.00€25mg160.00€50mg209.00€100mg271.00€250mg593.00€500mgTo inquire(2S,3S,4R)-5-(Allyloxy)-2,3,4-tris(benzyloxy)pentan-1-ol
CAS:Formula:C29H34O5Purity:90%Molecular weight:462.57735H-Cyclopropa[3,4]benz[1,2-e]azulen-5-one,9a-(acetyloxy)-1,1a,1b,4,4a,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-,(1aR,1bS,4aR,7aS,7bR,8R,9aS)-
CAS:Formula:C22H30O6Purity:98%Color and Shape:SolidMolecular weight:390.47Benzonitrile,2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-
CAS:Formula:C18H21N5O2Purity:98%Color and Shape:SolidMolecular weight:339.39163999999994Ref: IN-DA003QOB
1g56.00€5g126.00€10g175.00€25g563.00€50gTo inquire100gTo inquire100mg21.00€250mg25.00€1-Piperidinecarboxylic acid, 4-amino-3-fluoro-, phenylmethyl ester, (3R,4S)-rel-
CAS:Formula:C13H17FN2O2Purity:95%Color and Shape:SolidMolecular weight:252.2847(S)-5-Oxotetrahydrofuran-2-carboxylic acid
CAS:Formula:C5H6O4Purity:98%Color and Shape:SolidMolecular weight:130.0987Benzenemethanamine, 3,4-difluoro-α-methyl-, (alphaR)- (9CI)
CAS:Formula:C8H9F2NPurity:95%Color and Shape:LiquidMolecular weight:157.160566399999961,1'-Bicyclohexyl, 4-butyl-4'-propyl-, (trans,trans)-
CAS:Formula:C19H36Purity:95%Color and Shape:SolidMolecular weight:264.48914’-Hydroxy Atomoxetine-d3
CAS:Controlled ProductApplications A labelled metabolite of Atomoxetine. References Creighton, C.J., et al.: Bioorg. Med. Chem. Lett., 14, 15, 4083 (2004)Formula:C17H18D3NO2Color and Shape:Beige SolidMolecular weight:274.37(3aR,6aR)-1-Methyl-hexahydropyrrolo[3,4-b]pyrrole
CAS:Formula:C7H14N2Purity:97%Molecular weight:126.1995Benzenemethanol, α-(chloromethyl)-4-fluoro-, (αR)-
CAS:Formula:C8H8ClFOPurity:%Color and Shape:LiquidMolecular weight:174.5999PHORBOL 12-MYRISTATE 13-ACETATE
CAS:Formula:C36H56O8Purity:95%Color and Shape:SolidMolecular weight:616.8250399999998(S)-Octahydropyrazino[2,1-c][1,4]oxazine dihydrochloride
CAS:Formula:C7H16Cl2N2OPurity:98%Color and Shape:SolidMolecular weight:215.12074000000004Ref: IN-DA0092QS
1g165.00€5gTo inquire10gTo inquire25gTo inquire50gTo inquire100gTo inquire100mg98.00€250mg116.00€D-arabino-Hexose, 2-deoxy-3,4,6-tris-O-(phenylmethyl)-
CAS:Formula:C27H30O5Purity:95%Color and Shape:SolidMolecular weight:434.5241L-Glutamic acid,N-[4-[[[(6S)-2-amino-5-formyl-1,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl]methyl]amino]benzoyl]-, calcium salt (1:1)
CAS:Formula:C20H21CaN7O7Purity:98%Color and Shape:SolidMolecular weight:511.5014L-Phenylalanine, 4-(aminocarbonyl)-N-[(1,1-dimethylethoxy)carbonyl]-
CAS:Formula:C15H20N2O5Purity:98%Color and Shape:SolidMolecular weight:308.3297Benzenemethanamine, 2,4-difluoro-a-methyl-, (aS)-
CAS:Formula:C8H9F2NPurity:97%Color and Shape:LiquidMolecular weight:157.160566428-Oxo Ivermectin B1a (Impurity)
CAS:Impurity Ivermectin EP Impurity D Applications 28-Oxo Ivermectin B1a is an impurity of Ivermectin (I940800), an antiparasitic drug that is active against a wide variety of nematode and arthropod parasites and is used to treat scabies and lice in humans. An invitro inhibitor of SARS-CoV-2/ Covid-19. Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Campbell, W., et al.: Science, 221, 823 (1983); Glaziou, P., et al.: Trop. Med. Parasitol., 45, 253 (1994); Meinking, T., et al.: New Engl. J. Med., 333, 26 (1995); Caly, L., et al.: Antivir. Res., 178Formula:C48H72O15Color and Shape:NeatMolecular weight:889.084'-Acetyl Simvastatin
CAS:Controlled ProductImpurity Simvastatin EP Impurity B Applications 4'-Acetyl Simvastatin (Simvastatin EP Impurity B) is a Simvastatin (S485000) impurity. References Shioi, A., et al.: J. Phys. Chem., 99, 4750 (1995), Wang, L., et al.: J. Pharm. Biomed. Anal., 21, 1243 (2000), Vuletic, M., et al.: J. Pharm. Biomed. Anal., 37, 715 (2005),Formula:C27H40O6Color and Shape:White To Off-WhiteMolecular weight:460.601-Cyclohexene-1-carboxylic acid, 4,5-dihydroxy-3-oxo-, (4S,5R)-
CAS:Formula:C7H8O5Purity:98%Color and Shape:SolidMolecular weight:172.135419999999981H-Benzimidazole, 6-methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-, sodium salt (1:1)
CAS:Formula:C17H18N3NaO3SPurity:%Color and Shape:SolidMolecular weight:367.397889999999961-Azabicyclo[2.2.2]octan-3-amine, N-[(1R)-1-phenylethyl]-, hydrochloride (1:2), (3S)-
CAS:Formula:C15H24Cl2N2Purity:98%Color and Shape:SolidMolecular weight:303.2705Hexanedioic acid, 3-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-, 6-(1,1-dimethylethyl) ester, (3S)-
CAS:Formula:C25H29NO6Purity:97%Color and Shape:SolidMolecular weight:439.50085999999993T-BUTYL (2S)-2-[(BENZYLOXYCARBONYLAMINO)]-4-HYDROXYBUTYRATE
CAS:Formula:C16H23NO5Purity:97%Color and Shape:SolidMolecular weight:309.35751999999997D-threo-Pentitol, 2,5-anhydro-1,3,4-trideoxy-2-C-(2,4-difluorophenyl)-4-(hydroxyMethyl)-1-(1H-1,2,4-triazol-1-yl)-
CAS:Formula:C14H15F2N3O2Purity:98%Color and Shape:SolidMolecular weight:295.28461-Pyrrolidinecarboxylic acid, 4-hydroxy-2-methyl-, 1,1-dimethylethyl ester, (2R,4R)-
CAS:Formula:C10H19NO3Purity:97%Color and Shape:SolidMolecular weight:201.2628L-Proline, 4-[[(1,1-dimethylethyl)diphenylsilyl]oxy]-, (4R)-
CAS:Formula:C21H27NO3SiPurity:98%Color and Shape:SolidMolecular weight:369.5294799999999Butanoic acid, 4-[[1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl]amino]-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-, (2S)-
CAS:Formula:C29H32N2O6Purity:98%Color and Shape:SolidMolecular weight:504.5742Sitagliptin Triazecine Analog
CAS:Controlled ProductImpurity Sitagliptin Tablets EP Impurity FP-B Applications Sitagliptin Triazecine Analog is related to the family of Sitagliptin compounds which has recently been approved for the therapy of type II diabetes. References Ahren, B., et al.: Eur. J. Pharmacol. 521 164 (2005), Bergman, A., et al: Clin. Ther. 28, 55 (2006)Formula:C16H13F6N5O2Color and Shape:NeatMolecular weight:421.30Benzenepropanoic acid, β-amino-4-methoxy-, (βS)-
CAS:Formula:C10H13NO3Purity:95%Color and Shape:SolidMolecular weight:195.2151D-erythro-C18-Dihydro-D-sphingosine
CAS:Controlled ProductApplications Biosynthetic precursor of Sphingosine. Inhibits protein kinase C. References Merrill, A.H. Jr., et al.: Biochemistry, 28, 3138 (1989)Formula:C18H39NO2Color and Shape:NeatMolecular weight:301.51(S)-tert-Butyl 2-benzylpiperazine-1-carboxylate
CAS:Formula:C16H24N2O2Purity:95%Color and Shape:SolidMolecular weight:276.374trans-(1S,2S)-2-Aminocyclopentanol Hydrochloride
CAS:Formula:C5H12ClNOPurity:98%Color and Shape:SolidMolecular weight:137.6079(S)-1-BOC-4-(AMINOCARBOXYMETHYL)PIPERIDINE
CAS:Formula:C12H22N2O4Purity:98%Color and Shape:SolidMolecular weight:258.3141L-Methionine [S]-Sulfoximine
CAS:Controlled ProductFormula:C5H12N2O3SColor and Shape:NeatMolecular weight:180.23(R)-(+)-O-Desmethyl Carvedilol
CAS:Controlled ProductApplications An optically active metabolite of Carvedilol (C184625), a nonselective ß-adrenergic blocker with α-1-blocking activity. [α]D= +18.7 (c= 0.1 methanol) Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Sponer, G., et al.: J. Cardiovasc. Pharmacol., 9, 317 (1987), Fujimaki, M., et al.: Xenobiotica, 20, 1025 (1990), Ruffolo, R., et al.: Eur. J. Clin. Pharmacol., 38, S82 (1990), Clohs, L., et al.: J. Pharm. Biomed. Anal., 31, 407 (2003),Formula:C23H24N2O4Color and Shape:NeatMolecular weight:392.45Pyridine, 2-[(3R)-3-pyrrolidinyloxy]-, hydrochloride (1:2)
CAS:Formula:C9H14Cl2N2OPurity:95%Color and Shape:SolidMolecular weight:237.1263PNU 142586 Sodium Salt
CAS:Applications PNU 142586 Sodium Salt is an inactive metabolite of Linezolid (L466500). References Shinabarger, D., et al.: Antimicrob. Agents Chemother., 41, 2132 (1997), Wynalda, M., et al.: Drug Metab. Dispos., 28, 1014 (2000),Formula:C16H19FN3NaO6Color and Shape:White To Off-WhiteMolecular weight:391.33PRAMIPEXOLE HYDROCHLORIDE
CAS:Formula:C10H19Cl2N3SPurity:%Color and Shape:SolidMolecular weight:284.249N-(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)glycyl-L-proline
CAS:Formula:C17H26N2O4Purity:97%Color and Shape:SolidMolecular weight:322.39931,2,3-Oxathiazolidine-3-carboxylic acid, 4-ethyl-, 1,1-dimethylethyl ester, 2,2-dioxide, (4R)-
CAS:Formula:C9H17NO5SPurity:98%Color and Shape:SolidMolecular weight:251.3Pyridine, 2,6-bis[(4R)-4,5-dihydro-4-(1-methylethyl)-2-oxazolyl]-
CAS:Formula:C17H23N3O2Purity:95%Color and Shape:SolidMolecular weight:301.3834D-Phenylalanine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-4-methyl-
CAS:Formula:C25H23NO4Purity:98%Color and Shape:SolidMolecular weight:401.4544(S)-2-Phenylsuccinic acid
CAS:Formula:C10H10O4Purity:98%Color and Shape:SolidMolecular weight:194.184Calcifediol-d6
CAS:Controlled ProductApplications A metabolite of Vitamin D. The principal circulating form of vitamin D3, formed in the liver by hydroxylation at C-25. Calcium regulator. Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References orii, et al.: Arch. Biochem. Biophys., 120, 513 (1967), Blunt, et al.: Biochemistry, 7, 3317 (1968), Liu, et al.: Science, 311, 1770 (2006),Formula:C272H6H38O2Purity:>90%Color and Shape:Off-WhiteMolecular weight:406.67D-Gamma-Tocotrienol
CAS:Stability Light Sensitive Applications γ-Tocotrienol exhibits antioxidant properties and belongs to the vitamin E family. It is naturally found in wheat germ oil and bran. In addition, α-tocopherol and γ-tocotrienol derivatives are potential lead compounds for developing anticancer and antiproliferative agents against MCF-7 and MDA-MB-231 breast cancer cells and the A549 lung cancer cells. References Gagic, Z., et al.: Eur. J. Pharm. Sci. 88, 59 (2016); Guardiola, F., et al.: Food Chem. Toxicol., 34, 193 (1996); Kong, S., et al.: Food Chem., 120, 278 (2010); Aggarwal, B., et al.: Biochem. Pharmacol., 80, 1613 (2010)Formula:C28H42O2Color and Shape:YellowMolecular weight:410.63N-Fmoc-L-alanine-d4
CAS:Controlled ProductApplications N-Fmoc-L-alanine-d4 is the isotope labelled analog of N-Fmoc-L-alanine (F619945); the Fmoc-protected form of L-Alanine (A481500). L-Alanine is used to make in-vivo measurement of glucose and alanine metabolism in studies of patients with diabetes. L-Alanine is a non-essential amino acid for human development and is one of the 20 amino acids encoded by the genetic code. References Bier, D.M. et al.: Diabetes, 26, 1005 (1977); Capaldo, B. et al.: J. Clin. Endocrinol. Metab., 71, 1220 (1990); Giacca, A. et al.: Diabetes, 47, 1763 (1998)Formula:C18D4H13NO4Color and Shape:NeatMolecular weight:315.365-Iodo-2'-deoxycytidine
CAS:Formula:C9H12IN3O4Purity:98%Color and Shape:SolidMolecular weight:353.1137(3R,5R)-tert-Butyl 7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate
CAS:Formula:C37H43FN2O5Purity:98%Color and Shape:SolidMolecular weight:614.7461D-Glutamic acid, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-, 1-(2-propen-1-yl) ester
CAS:Formula:C23H23NO6Purity:97%Color and Shape:SolidMolecular weight:409.4318ISOCYANURIC ACID (S,S,S)-TRIGLYCIDYL ESTER
CAS:Formula:C12H15N3O6Purity:98%Color and Shape:SolidMolecular weight:297.264UDP-3-O[R-3-Hydroxymyristoyl]-N-acetylglucosamine Tris Salt (90%)
CAS:Controlled ProductApplications UDP-3-O[R-3-Hydroxymyristoyl]-N-acetylglucosamine Tris Salt is a lipid A precursor for Escherichia coli. References Anderson, M. S. et al.: Biochem., 27, 1908 (1988);Formula:C35H64N4O22P2Purity:90%Color and Shape:NeatMolecular weight:954.84D-Phenylalanine, N-[(1,1-dimethylethoxy)carbonyl]-4-(1,1-dimethylethyl)-
CAS:Formula:C18H27NO4Purity:95%Color and Shape:SolidMolecular weight:321.4113D-Alanine, N-[(1,1-dimethylethoxy)carbonyl]-N-methyl-
CAS:Formula:C9H17NO4Purity:98%Color and Shape:SolidMolecular weight:203.23561H-Indazol-5-amine, 4,5,6,7-tetrahydro-, hydrochloride (1:1), (5S)-
CAS:Formula:C7H12ClN3Purity:97%Color and Shape:SolidMolecular weight:173.64331H-Imidazole, 5-[(1S)-1-(2,3-dimethylphenyl)ethyl]-
CAS:Formula:C13H16N2Purity:98%Color and Shape:SolidMolecular weight:200.27953999999997(2S,3S)-3-Amino-2-[[(2Z)-2-(2-amino-4-thiazolyl)-2-[(1-carboxy-1-methylethoxy)imino]acetyl]amino]but
CAS:Controlled ProductApplications (2S,3S)-3-Amino-2-[[(2Z)-2-(2-amino-4-thiazolyl)-2-[(1-carboxy-1-methylethoxy)imino]acetyl]amino]butanoic Acid is an impurity of Aztreonam (A965200), the first totally synthetic monocyclic β-lactam antibiotic. References Murugan, R., Narayanan, S.S.: Anal. Chem. Indian J., 8, 36 (2009); Sykes, R.B., et al.: Antimicrob. Agents Chemother., 21, 85 (1982); Florey, K., et al.: Anal. Profiles Drug Subs., 17, 1 (1988)Formula:C13H19N5O6S•x(C2HF3O2)Color and Shape:NeatMolecular weight:373.3811402Nabilone
CAS:Controlled ProductApplications A synthetic cannabinoid with antiemetic, antiglaucoma, and CNS activity. Antiemetic. Controlled substance (hallucinogen). Synthetic Cannabinoids References Rubin, A., et al.: Clin. Pharmacol. Ther., 22, 85 (1977), Stark, P., et al.: J. Pharmacol. Exp. Ther., 214, 124 (1980), Souter, R.W., et al.: Anal. Profiles Drug Subs., 10, 499 (1981), Ward, A., Drugs, 30, 127 (1985),Formula:C24H36O3Color and Shape:Off White Crystalline PowderMolecular weight:372.54RuCl2[(S)-dm-segphos®][(S,S)-dpen]
CAS:Formula:C60H60Cl2N2O4P2RuColor and Shape:Light yellow to Brown powder to crystalMolecular weight:1,107.07trans-4-Aminocyclohexanecarboxylic acid hydrochloride
CAS:Formula:C7H14ClNO2Purity:98%Color and Shape:SolidMolecular weight:179.6446Ferrocene, [(4S)-4,5-dihydro-4-(1-methylethyl)-2-oxazolyl]-
CAS:Formula:C16H19FeNOPurity:98%Color and Shape:SolidMolecular weight:297.17323-Pyrrolidineacetic acid, 1-[(1,1-dimethylethoxy)carbonyl]-, (3R)-
CAS:Formula:C11H19NO4Purity:98%Color and Shape:SolidMolecular weight:229.2729(S)-2-(2-Chlorophenyl)-2-hydroxyacetic acid
CAS:Formula:C8H7ClO3Purity:97%Color and Shape:SolidMolecular weight:186.5924(S)-tert-Butyl (1-(4-bromophenyl)ethyl)carbamate
CAS:Formula:C13H18BrNO2Purity:98%Color and Shape:SolidMolecular weight:300.1915Carbamic acid, N-(3R)-3-pyrrolidinyl-, 1,1-dimethylethyl ester, hydrochloride (1:1)
CAS:Formula:C9H19ClN2O2Purity:97%Color and Shape:SolidMolecular weight:222.7124BB-22 3-Carboxyindole Metabolite
CAS:Controlled ProductApplications BB-22 3-Carboxyindole Metabolite is an intermediate of MDMB-CHMICA (M199520). MDMB-CHMICA is an analogue of N-[(1S)-1-(Aminocarbonyl)-2-methylpropyl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide (A603135), an indazole derivative developed as a CB1 receptor modulator used in the treatment of CB1-mediated diseases. References Nahoko, U., et al.: Forensic. Toxicol., 31, 93 (2013)Formula:C16H19NO2Color and Shape:NeatMolecular weight:257.30(S)-o-Methyl-a-phenylethylamine
CAS:Formula:C9H13NPurity:95%Color and Shape:SolidMolecular weight:135.2062Lobeline hydrochloride
CAS:Formula:C22H28ClNO2Purity:98%Color and Shape:SolidMolecular weight:373.9162(R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethanamine hydrochloride
CAS:Formula:C10H10ClF6NPurity:97%Color and Shape:SolidMolecular weight:293.6365(R)-Morpholin-3-ylmethanol hydrochloride
CAS:Formula:C5H12ClNO2Purity:95%Color and Shape:SolidMolecular weight:153.6073Cobalt, [[2,2'-[(1S,2S)-1,2-cyclohexanediylbis[(nitrilo-κN)methylidyne]]bis[4,6-bis(1,1-dimethylethyl)phenolato-κO]](2-)]-, (SP-4-2)-
CAS:Formula:C36H52CoN2O2Purity:98%Color and Shape:SolidMolecular weight:603.7435[NH2Me2][(RuCl((R)-tolbinap))2(μ-Cl)3]
CAS:Formula:C98H88Cl5NP4Ru2Color and Shape:Light yellow to Amber to Dark green powder to crystalMolecular weight:1,783.07(S)-(+)-3,3-Dimethyl-2-butylamine
CAS:Formula:C6H15NPurity:97%Color and Shape:LiquidMolecular weight:101.198-BENZYL-3-EXO-(3-ISOPROPYL-5-METHYL-4H-1,2,4-TRIAZOL-4-YL)-8-AZABICYCLO[3.2.1]OCTANE
CAS:Formula:C20H28N4Purity:95%Color and Shape:SolidMolecular weight:324.4631S-(5'-deoxyadenosin-5'-yl)-L-Homocysteine
CAS:Formula:C14H20N6O5SPurity:97%Color and Shape:SolidMolecular weight:384.4108Boc-trans-4-Tosyloxy-L-proline methyl ester
CAS:Formula:C18H25NO7SPurity:95%Color and Shape:SolidMolecular weight:399.4586(R)-(-)-N-(3,5-Dinitrobenzoyl)-α-phenylethylamine ,
CAS:Formula:C15H13N3O5Purity:97%Molecular weight:315.2808rac-Sitagliptin (S)-Maleate Adduct (mixture of diastereomers)
Controlled ProductFormula:C20H19F6N5O5Color and Shape:NeatMolecular weight:523.39Cyclohexanol, 2-amino-, hydrochloride, (1R-trans)-
CAS:Formula:C6H14ClNOPurity:97%Color and Shape:SolidMolecular weight:151.63446(R)-2-hydroxypropaniMidaMide hydrochloride
CAS:Formula:C3H9ClN2OPurity:95%Color and Shape:SolidMolecular weight:124.56936(S)-2-Acetyl-pyrrolidine Hydrochloride
CAS:Formula:C6H12ClNOPurity:98%Color and Shape:SolidMolecular weight:149.6186Ceftazidime Pentahydrate
CAS:Formula:C16H19N5O5S2Purity:%Color and Shape:SolidMolecular weight:425.4826(S)-Ethyl 2-((tert-butoxycarbonyl)amino)-3-(4-hydroxyphenyl)propanoate
CAS:Formula:C16H23NO5Purity:98%Color and Shape:SolidMolecular weight:309.3575tert-butyl N-[(3S,4S)-4-fluoropiperidin-3-yl]carbamate
CAS:Formula:C10H19FN2O2Purity:97%Color and Shape:SolidMolecular weight:218.2685N-(2-Thiophenesulfonyl)-L-prolinamide
CAS:Formula:C9H12N2O3S2Purity:95%Color and Shape:SolidMolecular weight:260.3332Rasagiline-13C3 Hydrochloride
CAS:Controlled ProductApplications Rasagiline-13C3 Hydrochloride is a labeled hydrochloride salt analogue of Rasagiline (R126000), a selective irreversible MAO-B inhibitor. Rasagiline is an Antiparkinsonian agent. References Rabey, J.M. et al.: Clin. Neuropharmacol., 23, 324 (2000); Glezer, S. et al.: Eur. J. Pharmacol., 472, 173 (2003); Youdim, M.B.H. et al.: Biochem. Pharmacol., 66, 1635 (2003); Chen, J.J. et al.: J. Clin. Pharmacol., 45, 878 (2005);Formula:C913C3H14ClNColor and Shape:NeatMolecular weight:210.681,3-Dioxolane-4-methanamine, 2,2-dimethyl-, (4R)-
CAS:Formula:C6H13NO2Purity:98%Color and Shape:SolidMolecular weight:131.17291-Naphthalenecarboxylic acid, 1,2,3,4-tetrahydro-, (1R)-
CAS:Formula:C11H12O2Purity:98%Color and Shape:SolidMolecular weight:176.2118